Adaptimmune Therapeutics plc (ADAP)

USD 0.61

(1.1%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 282.61 Million 328.91 Million 469.54 Million 451.14 Million 181.54 Million 276.73 Million
Total Current Assets 207.55 Million 255.37 Million 415.45 Million 398.15 Million 120.48 Million 231.09 Million
Cash And Short Term Investments 146.93 Million 204.6 Million 369.58 Million 368.21 Million 89.54 Million 205.13 Million
Cash and Cash Equivalents 143.99 Million 108.03 Million 149.94 Million 56.88 Million 50.41 Million 68.37 Million
Short Term Investments 2.94 Million 96.57 Million 219.63 Million 311.33 Million 39.13 Million 136.75 Million
Net Receivables 46.91 Million 7.43 Million 752 Thousand 139 Thousand -1.45 Million 192 Thousand
Inventory 1.32 Million 1.27 Million 746 Thousand 2.08 Million 1.45 Million 1.08 Million
Other Current Assets 13.69 Million 43.33 Million 45.12 Million 29.79 Million 30.94 Million 25.76 Million
Total Non-Current Assets 75.06 Million 73.54 Million 54.08 Million 52.99 Million 61.05 Million 45.64 Million
Net PPE 71.7 Million 71.53 Million 51.36 Million 46.65 Million 51.85 Million 36.11 Million
Good Will And Intangible Assets 330 Thousand 442 Thousand 1 Million 1.73 Million 2.19 Million 1.47 Million
Good Will - - - - - -
Intangible Assets 330 Thousand 442 Thousand 1 Million 1.73 Million 2.19 Million 1.47 Million
Long-Term Investments 3.02 Million 1.56 Million 1.71 Million 4.6 Million 4.49 Million 4.09 Million
Tax Assets -3.02 Million -1.56 Million -1.71 Million -4.6 Million -4.49 Million -4.09 Million
Other Non Current Assets 3.02 Million 1.56 Million 1.71 Million 4.6 Million 6.99 Million 8.05 Million
Other Assets - - - - - -
Total Liabilities 243.1 Million 247.03 Million 263.58 Million 109.91 Million 57.9 Million 29.85 Million
Total Current Liabilities 72.78 Million 64.5 Million 62.54 Million 39.07 Million 34.34 Million 24.43 Million
Account Payables 8.12 Million 4.75 Million 8.11 Million 6.38 Million 6.35 Million 4.08 Million
Tax Payables 1.39 Million - - - - -
Short Term Debt 5.38 Million 2.72 Million 2.32 Million 2.77 Million 2.49 Million -
Deferred Revenue 28.97 Million 23.52 Million 22.19 Million 2.83 Million 2.12 Million -
Other Current Liabilities 30.3 Million 33.5 Million 29.9 Million 27.07 Million 23.36 Million 20.35 Million
Total Non Current Liabilities 170.31 Million 182.53 Million 201.04 Million 70.84 Million 23.56 Million 5.41 Million
Long-Term Debt 19.85 Million 20.34 Million 23.14 Million 20.93 Million 22.96 Million -
Deferred Revenue Non Current 149.06 Million 160.89 Million 177.22 Million 49.26 Million - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.4 Million 1.29 Million 673 Thousand 644 Thousand 598 Thousand 3.99 Million
Other Liabilities - - - - - -
Total Equity 39.51 Million 81.87 Million 205.96 Million 341.22 Million 123.63 Million 246.88 Million
Stock Holders Equity 39.51 Million 81.87 Million 205.96 Million 341.22 Million 123.63 Million 246.88 Million
Common Stock 1.86 Million 1.39 Million 1.33 Million 1.32 Million 943 Thousand 939 Thousand
Retained Earnings -1.02 Billion -909.3 Million -743.84 Million -585.75 Million -455.66 Million -318.49 Million
Accumulated other comprehensive income -3.74 Million -875 Thousand -11.14 Million -10.04 Million -7.26 Million -9.76 Million
Common Stock Equity 39.51 Million 81.87 Million 205.96 Million 341.22 Million 123.63 Million 246.88 Million
Capital Lease Obligation 19.85 Million 23.07 Million 25.46 Million 23.71 Million 25.45 Million -
Total Investments 5.97 Million 96.57 Million 219.63 Million 311.33 Million 39.13 Million 136.75 Million
Total Debt 25.23 Million 23.07 Million 25.46 Million 23.71 Million 25.45 Million 136.75 Million
Net Debt -118.75 Million -84.95 Million -124.48 Million -33.17 Million -24.95 Million 68.37 Million

Balance Sheet Charts